Morphine Sulfate Oral Solution
Defective container: Oral solution leaking from container.
1,134 recalls, newest first
Defective container: Oral solution leaking from container.
Lack of Sterility Assurance
Lack of Sterility Assurance
Lack of Sterility Assurance
Lack of Sterility Assurance
Microbial Contamination of Non Sterile Products; out of specification Total Plate Count
Superpotent Drug: high out-of-specification result for magnesium.
Presence of foreign substance: glass particle
Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.
Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.
Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.
Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.
Subpotent Drug: found to be below the specification for labeled assay.
Subpotent Drug: found to be below the specification for labeled assay.
Subpotent Drug: found to be below the specification for labeled assay.
GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.
GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.
GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.
GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.
GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.
GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.
Marketed without an approved NDA/ANDA: product label states it contains anabolic steroids.
Marketed without an approved NDA/ANDA: product label states it contains anabolic steroids.
CGMP Deviations: Possibility of the presence of microbial contamination in the water used to manufacture this product lot.
Labeling: Label Mix-up: One bottle of Eliquis 5 mg tablet was found to contain lower-strength Eliquis 2.5 mg tablets only instead of the labeled 5 mg tablets.